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Clusters of cases of sore throat associated
with isolation of nontoxigenic Corynbacterium
diphtheriae were detected in gay men attending a
genitourinary medicine clinic, military recruits,
and children from a religious community in
England and Wales in the late 1980s to mid-
1990s (1-4). To determine the public health
importance of the increase in cases, the Public
Health Laboratory Service’s (PHLS’s) Strepto-
coccus and Diphtheria Reference Unit and the
PHLS Communicable Disease Surveillance
Centre obtained more complete clinical informa-
tion on nontoxigenic isolates referred in 1995 and
1996. Isolates received in 1995 were further
characterized by molecular typing (ribotyping).
The Study
Laboratories in England and Wales routinely
submit isolates of C. diphtheriae to the PHLS
Streptococcus and Diphtheria Reference Unit for
confirmation and toxin determination by both
phenotypic (Elek and other immunoassays) and
genotypic (polymerase chain reaction) methods
(5,6). Routine screening of throat swabs with
selective culture media for C. diphtheriae was
encouraged in public health laboratories in
England and Wales (7). Clinical and epidemio-
logic information was obtained from question-
naires sent to referring laboratories and from
laboratory request forms. Responsibility for
completion and return of the enhanced surveil-
lance questionnaires was taken by laboratory
staff, in consultation with senior medical
microbiologists and attending physicians with
access to laboratory and medical records. The
questionnaires, which included history of recent
travel, symptoms and signs of illness, general
medical history, clinical management (particu-
larly antibiotic treatment, contact tracing, and
treatment of contacts) and bacteriologic and
virologic investigations, were sent retrospec-
tively for isolates received by the PHLS
diphtheria unit from January to June 1995 and
prospectively through 1996 (8). Isolates con-
firmed as nontoxigenic C. diphtheriae during
1995 were ribotyped. The isolates were referred
from laboratories in England, Wales, Scotland,
the Channel Islands, and the Isle of Man.
Analysis of ribotype patterns was done by using
Taxotron (Institut Pasteur, France) software, as
previously described (9).
In 1995 and 1996, PHLS confirmed 265
isolates from residents of England and Wales as
nontoxigenic  C. diphtheriae (Figure 1). The
isolates were submitted by 80 laboratories
located throughout each country; 28 (35%) were
public health laboratories. Each laboratory
submitted 1 to 27 isolates. Questionnaires were
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Figure 1. Annual number of isolates of Corynebacte-
rium diphtheriae confirmed by the Public Health
Laboratory Service’s Streptococcus and Diphtheria
Reference Unit, from residents of England and Wales,
1986-1999.
Table 1. English and Welsh patients with sore throats whose throat swabs yielded nontoxigenic Corynebacterium
diphtheriae, by sex, 1995 and 1996
Male patients Female patients Not recorded Total
Clinical setting No.    %  No.    % No.    % No.    %
General practice 50   52   98   74 3   38 151   63
Outpatients 15   15     9     7 1   13   25   11
GUM clinica 11   11     0     0 1   13   12     5
Inpatients   8     8     6     5 0     0   14     6
Other   2     2     5     4 0     0     7     3
Not recorded 11   11   15   11 3   38   29   12
All settings 97 100 133 100 8 100 238 100
aGUM = genitourinary medicine.
Table 2. English and Welsh patients with sore throats whose throat swabs yielded nontoxigenic Corynebacterium
diphtheriae, by age, 1995 and 1996
Age
<15 15-24 25-34 35+ All ages
Clinical Setting No.  %  No.  % No.  % No.  %  No.   %
General practice 20 13 103 68 24 16   4   3 151 100
Outpatients   1   4   15 58   7 31   2   8   25 100
GUM clinica   0   0     6 50   4 33   2 17   12 100
Inpatients   4 29     8 57   2 14   0   0   14 100
Other   0   0     2 29   4 57   1 14     7 100
Not recorded   5 17   14 47   8 30   2   7   29 100
All settings 30 13 148 62 49 21 11   5 238 100
aGUM = genitourinary medicine.
returned for 236 (89%) isolates. No pharyngeal
membrane or systemic toxicity was reported. The
age range of patients whose isolates were tested
was 1 to 87 (median 20) years.
Two hundred forty-seven (93%) isolates were
from the throat, ten (4%) from skin lesions, one
from blood, one from a nose swab, and one from
bronchial washings; five were from unrecorded
sites. Biotype var gravis accounted for 223
(84%), var mitis for 33(12%), and var belfanti for
9 (3%) isolates.
Of the 247 throat isolates, 238 were obtained
as a result of clinical evaluation of patients with
sore throats, and 9 were obtained from contacts of
these patients. Of the 238 isolates obtained
during evaluations, more than 25% were from male
attendees at general outpatient or genitourinary
medicine outpatient clinics (Table 1). Of isolates
from females patients, 7% were from general
outpatient clinics, and none were from genitouri-
nary medicine outpatient clinics. Most isolates
were from 15- to 24-year-old patients (Table 2). Of
238 throat isolates, 29 (12%) were from patients
who had traveled outside the United Kingdom in
the preceding 3 months, 20 to Western Europe, 4
to Australasia, 2 to Africa, 2 to the Indian
subcontinent, and 1 to the Caribbean. Fever,
lymphadenopathy, or both were reported in
association with 72 (30%) of throat isolates.
Nontoxigenic C. diphtheriae was reported as the
predominant organism in 171 (72%) of the 238
throat swabs (Table 3) but was mixed with beta-
hemolytic streptococci in 67 (28%). Penicillin was
prescribed for 100 patients and a macrolide for
66, for a total of 166 (70%) patients treated
according to current U.K. guidelines (10). Other
antibiotics were prescribed for 7 patients and
none for the rest. Viral throat cultures, reported
for 10 (4%) of the 238 patients, were negative.642
Dispatches
Emerging Infectious Diseases Vol. 6, No. 6, November–December 2000
Table 3. Pathogens in mixed growth with nontoxigenic
Corynebacterium diphtheriae in throat swabs from English
and Welsh patients with sore throats, 1995 and 1996
Pathogen  No.    %
Lancefield Group A streptococci   26   11
Lancefield Group C streptococci   30   13
Lancefield Group G streptococci   11     5
None 171   72
Total 238 100
Table 4. Throat isolates of nontoxigenic Corynebacterium diphtheriae submitted to the Public Health Laboratory
Service’s Streptococcus and Diphtheria Reference Unit, from U.K. residents,a 1995
Travel outside
  U.K. within
    previous
Site of isolate    3 months No. ribotyped Ribotypes
Isolates from residents of England and Wales
Throat  No 96 78A,3B,1C,1D,5F,1G,1I,1J,1L,1N,1O,1P,1T
Throat Yes 11 7A,1B,1E,1F,1U
Skin Yes   5 1D,1H,1J,1M,1W
Blood Yes   1 1Q
Bronchial washings  No   1 1S
Nose  No   1 1V
Total 115
Isolates from contacts of residents of England and Wales
Throat  No   6 5A,1Q
Total 121
Isolates from residents of Scotland, Channel Islands, and Isle of Man
Throat No   8 4A,1K,1L,2R
Total U.K. 129
aU.K. = England, Wales, Scotland, Channel Islands, and Isle of Man.
Positive serologic results for infectious mononu-
cleosis were reported in 10 (4%) patients. Seven
isolates were associated with HIV infection, eight
with psoriasis, one with gonorrhea, two with
malaria, and one with cytomegalovirus infection
and Crohn disease. Four of five laboratories
referring 10 or more isolates reported that they
had screened all throat swabs with selective
media for C. diphtheriae during 1995 and 1996.
These laboratories were located at two teaching
hospitals in central London (25 and 19 isolates)
and two public health laboratories, one in the
northwest of England (13 isolates) and the other
in Wales (10 isolates). These 67 isolates were
obtained from screening 32,345 throat swabs
during the survey period. This rate corresponds
to an overall rate of two isolates per thousand
throat swabs (1.2 to 2.9 isolates per thousand
throat swabs for each individual laboratory). Of
the 10 skin isolates, 2 were var gravis, 7 var mitis,
and 1 var belfanti. Nine were associated with
travel outside the United Kingdom in the
previous 3 months: to Africa (three patients), the
Indian subcontinent (one patient), the Caribbean
(two patients), and Southeast Asia (three
patients). The positive blood culture was biotype
var mitis, obtained from a 2-year-old with
congenital heart disease whose illness was
diagnosed as endocarditis 3 weeks after
returning from Pakistan. The isolate from the
nose was var belfanti mixed with Klebsiella
aerogenes, taken from a 23-year-old man of
Pakistani origin, who had a 3-month history of
rhinitis but had not traveled in the preceding 3
months. The isolate from bronchial washings was
var belfanti, associated with a malignant lung
tumor in a 68-year-old man.
Taxotron analysis was undertaken in 121
(90%) of 135 specimens obtained for isolation
from referrals from laboratories in all eight
health regions in England and Wales during
1995; 115 of these had been obtained through
clinical evaluation and 6 through contact tracing
(Table 4). Travel outside the United Kingdom in
the preceding 3 months was reported in
association with isolates from 17 patients (Tables
4 and 5). Eight additional isolates that had been
submitted by laboratories in Scotland, the
Channel Islands, and the Isle of Man were
ribotyped (Table 4). Twenty-three distinct
patterns were detected and were designated A to
W (Figure 2 and Tables 4 and 5). Ribotypes A, B,
C, and D were biotype gravis; ribotypes E, F, G,643
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Figure 2. BstEII rRNA gene profiles of nontoxigenic
Corynebacterium diphtheriae from isolates submitted
to the Public Health Laboratory Service’s Streptococ-
cus and Diphtheria Reference Unit from U.K.
residents,* 1995. Lanes 1, 4, 7, 10, 13, 16, 19, 22, 25,
28, 31, and 34 contain lambda HindIII digests as size
standard (sizes indicated on left). The remaining
tracks show ribotypes A to W: lane 2, 95/13 (A); lane 3,
95/281 (B); lane 5, 95/384 (C); lane 6, 95/358 (D); lane
8, 95/220 (E); lane 9, 95/258 (F); lane 11, 95/277 (G);
lane 12, 95/515 (H); lane 14, 95/173 (I); lane 15, 95/171
(J); lane 17, 95/382 (K); lane 18, 95/167 (L); lane 20, 95/
340 (M); lane 21, 95/428 (N); lane 23, 95/424 (O); lane
24, 95/453 (P); lane 26, 95/418 (Q); lane 27, 95/23 (R);
lane 29, 95/338 (S); lane 30, 95/18 (T); lane 32, 95/324
(U); lane 33, 95/389 (V); lane 35, 95/21 (W).
U.K. = England, Wales, Scotland, Channel Islands, and Isle
of Man.
Table 5. Nontoxigenic Corynebacterium diphtheriae
isolates from patients who traveled outside England and
Wales in the previous 3 months, submitted to the Public
Health Research Laboratory’s Streptococcus and
Diphtheria Reference Unit, 1995
Residencea   Destination Ribotype   Site
London     Australia A Throat
London   Sierra Leone A Throat
Northwest       Cyprus A Throat
Northwest      Holland A Throat
Northwest Canary Islands A Throat
Northwest        Spain A Throat
Wales     Germany A Throat
London       France B Throat
London      Vietnam D   Skin
London       Gambia E Throat
London Canary Islands F Throat
London        Sudan H   Skin
Southeast     Philippines J   Skin
London        Ghana M   Skin
West Midlands      Pakistan Q  Blood
London       Morocco U Throat
West Midlands      Jamaica W   Skin
aEnglish Health Regions and Wales.
H, I, J, K, L, M, N, O, P, and Q were biotype
mitis; and ribotypes R, S, T, U, V, and W were
biotype belfanti.
Ribotype A was isolated only from the throat
and accounted for 90 (74%) of 121 isolates from
residents of England and Wales (Table 4). The
isolates represented 78 of the 96 throat isolates
from specimens obtained during clinical evalua-
tion and not associated with recent travel, 7 of
11 throat isolates taken at investigation and
associated with recent travel, and 5 of 6 throat
isolates obtained at contact tracing (Tables 4
and 5). Ribotype A also accounted for 4 of 8 throat
isolates obtained at investigation from residents
of Scotland, the Channel Islands, and Isle of
Man (Table 4).
The remaining ribotype strains accounted for
one to five isolates and were associated with a
single health region or with travel outside the
United Kingdom (Tables 4 and 5). Ribotype E was
isolated from the throat of one person who had
recently traveled to Gambia (Table 5). The five
ribotypes from skin isolates were related to travel
(Table 5); ribotypes H, M, and W were present in
single isolates, while ribotypes D and J were also
detected in nontravel-related throat isolates.
Ribotype Q was isolated from blood of the 2-year-
old with congenital heart disease and from the
throat of a 4-year-old sibling. The nose isolate
from the 23-year-old patient of Pakistani origin
was ribotype V, and that obtained from bronchial
washings of the 68-year-old man was ribotype S.
All ribotypes from contacts were the same as
their index case isolates. Ribotypes A, G, N, Q, P,
L, and H formed a cluster with a genetic distance
of <0.2, indicating greater than 80% genetic
homology. Ribotypes L and H exhibited more
than 90% genetic similarity.
Conclusions
One invasive infection with C. diphtheriae
was associated with known risk factors. A single
case of endocarditis without recognized risk
factors was reported in England immediately
before the survey (11). This picture is similar to
that of an Australian series in which three of
seven cases of invasive infection had no
predisposing risk factors (12). Most isolates were
from throat swabs of young adults in primary
care. The preponderance of female patients
reflects the pattern of age- and sex-specific
consultation rates for acute pharyngitis and644
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tonsillitis (ICD 9th Revision codes 462 and 463)
seen in general practice (13). Men attending
genitourinary medicine clinics accounted for 5%
of throat isolates, but there were no isolates in
female patients from such settings. This is
consistent with clustering previously noted in
gay men but could be due to laboratory practice in
hospitals serving large gay populations.
It is not known whether nontoxigenic
C. diphtheriae strains were responsible for the
illnesses that prompted the study. More than
25% of the 238 throat isolates obtained at
investigation of sore throats were associated with
beta-hemolytic streptococcal infection, infectious
mononucleosis, or another illness; negative
results for viral culture of the throat and for
infectious mononucleosis were reported in a small
proportion of the remainder. Community-based
carriage studies and case-control studies,
supported by comprehensive virologic investiga-
tion, will be required to obtain more complete
information on the pathogenicity or copathogenici-
ty of nontoxigenic C. diphtheriae in throat
isolates.
Current U.K. guidelines state that when
identified, nontoxigenic C. diphtheriae be regarded
as a potential pathogen and be treated with
penicillin or erythromycin if the patient has
symptoms (10). Treatment was generally in
accordance with these guidelines, but contact
tracing, undertaken in 68 (26%) patients, and
administration of a diphtheria immunization
booster to 18 (8%) patients were not recommended.
The few nontoxigenic C. diphtheriae isolates
associated with chronic skin ulcers were mainly
associated with recent travel to tropical zones.
A total of 23 distinct ribotypes were observed.
However, ribotype A accounted for most isolates,
was isolated exclusively from the throat, and was
detected in isolates obtained throughout the
United Kingdom. Seven of eleven throat isolates
associated with a recent history of travel were
also ribotype A, and it is possible that these were
acquired in the U.K. Ribotype A predominated
and appeared to circulate freely within the U.K.
in 1995, which suggests that this strain may have
some advantage in terms of transmissibility or
pathogenic potential.
If nontoxigenic strains of C. diptheriae vary
in factors associated with increased transmissi-
bility of pathogenic potential, toxigenic strains
may also vary in these factors. Toxigenic strains
with these factors could be more likely than
toxigenic strains without these factors to produce
epidemics. This type of relationship may explain
the appearance of an epidemic clone in the
Russian diphtheria epidemic of the 1990s.
The marked variation in number of
nontoxigenic C. diphtheriae isolates referred by
laboratories in different regions probably re-
flected differences in the use of selective culture
media for C. diphtheriae and practice in referral
of isolates to PHLS. Increased professional
awareness of the risk for imported diphtheria
during the 1990s would have been expected to
have increased both of these factors and may
explain most, if not all, of the increase in the
number of nontoxigenic C. diphtheriae isolates
ascertained by the PHLS Streptococcus and
Diphtheria Reference Unit during this period
(Figure 1).
It has been suggested that nontoxigenic
strains could become toxigenic by acquiring
the tox gene, assuming that the chromosomal
diphtheria toxin repressor gene (dtxR) is functional
(14-16). However, no reports of membrane or
systemic toxicity were received for any of our
isolates, and ribotype patterns in the U.K.
isolates for toxigenic and nontoxigenic strains
differed. The rise in nontoxigenic strains from
1985 to 1996 and thereafter has not been
accompanied by a rise in toxigenic isolates
(Figure 1). These observations suggest that
conversion to toxin production had not occurred
despite continuing circulation of nontoxigenic
strains. However, documented introductions
of toxigenic C. diphtheriae into the U.K. are
extremely rare.
Results from the four laboratories that
routinely screen all throat isolates with selective
culture media indicated a low isolation rate. This
may not be seen as a cost-effective activity by
many laboratories; less biased and cost-effective
surveillance data could be obtained by undertak-
ing selective culture for C. diphtheriae in
population-based samples, accompanied by strict
compliance with reporting.
Our data confirm the known association of
nontoxigenic strains with localized disease and
with occasional cases of invasive infection,
particularly endocarditis. There was no evidence
that nontoxigenic C. diphtheriae would have
posed an increasing threat to public health in
England and Wales during the survey period.645
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